SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-298387
Filing Date
2018-10-12
Accepted
2018-10-12 16:13:59
Documents
3
Period of Report
2018-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d637888d8k.htm 8-K 31825
2 EX-10.1 d637888dex101.htm EX-10.1 69849
3 EX-10.2 d637888dex102.htm EX-10.2 69782
  Complete submission text file 0001193125-18-298387.txt   172725
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 181120374
SIC: 2834 Pharmaceutical Preparations